Exploring the Global Immunohematology Market: A Comprehensive Overview

The immunohematology market size has grown strongly in recent years. It will grow from $2.34 billion in 2023 to $2.49 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to advancements in blood transfusion science, prevalence of blood disorders, expansion of blood banks, government initiatives for blood safety, increased surgical procedures, awareness of transfusion-related risks.

The immunohematology market size is expected to see strong growth in the next few years. It will grow to $3.04 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing demand for point-of-care testing, emergence of novel blood products, expansion of healthcare infrastructure, genetic testing for blood compatibility, regulatory support for blood safety. Major trends in the forecast period include automation and high-throughput systems, molecular blood typing methods, antibody detection techniques, patient blood management programs, integration of ai in analysis, telemedicine integration..

Market Overview -
Immunohematology is a branch of laboratory medicine that studies blood groups and the body's immune response to foreign substances, particularly in blood transfusions. Immune hematological techniques are used to locate and address diagnostic issues in patients with hematological conditions, such as auto-immune hemolytic anemia.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Immunohematology Market's Surge Amidst Hematological Disorders
The rising prevalence rate of hematological disorders is expected to propel the growth of the immunohematology market going forward. Hematological disorders are a diverse group of conditions that affect the blood and the components of the blood, such as red blood cells, white blood cells, platelets, and plasma. Immunohematology is essential for safe and effective blood transfusions, as it helps to prevent transfusion reactions caused by incompatible blood types or the presence of antibodies in the recipient's blood. Immunohematology techniques are also used to diagnose and treat diseases related to the immune system, which may impact the hematological system. For Instance, in 2020, according to Cancer Research UK, a UK-based research organization, the average number of new leukemia cases caused by hematological disorders in the UK is expected to climb from roughly 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Therefore, the rising prevalence rate of hematological disorders is driving the growth of the immunohematology market.

Competitive Landscape -
Major companies operating in the immunohematology market report are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Nihon Kohden Corporation, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Harvard bioscience Inc., Cenogenics Corporation, Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Cellnovo Group, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Ortho Clinical Diagnostics Sets New Standards In Immunohematology
Technological advancements are a popular trend in the immunohematology market. Major companies operating in the immunohematology market are focused on developing innovative technologies to sustain their position in the market. For Instance, in October 2021, Ortho Clinical Diagnostics, a US-based diagnostics company, announced the launch of new capabilities for its Immediate Spin Crossmatch (ISXM) system for ORTHO VISION and ORTHO VISION MAX Analyzers. The ISXM system is a comprehensive transfusion solution that combines multiple instruments and software applications to streamline and automate immunohematology testing and processing. ISXM is used in blood transfusions to identify ABO blood type incompatibility between recipient serum and plasma and donor red blood cells. Although more laboratories are using electronic crossmatch, many still use full crossmatches (AHG/IAT). An ISXM test must also be finished in addition to a full crossmatch.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Key Segments -
The immunohematology market covered in this report is segmented -

1) By Product: Analyzers And Systems, Reagents
2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Emt), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3) By Disease: Blood-Related Diseases, HIV, Hepatitis
4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamic

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.